In an adult patient on antidepressant therapy who reports reduced libido, erectile dysfunction, or delayed orgasm, what are the recommended treatment strategies for these sexual side effects?

Treatment of Antidepressant-Induced Sexual Dysfunction

For patients experiencing sexual side effects from antidepressants, the most effective evidence-based approach is to switch to bupropion or augment the current antidepressant with bupropion, or for men with erectile dysfunction specifically, add a PDE5 inhibitor like sildenafil.

Initial Assessment

When a patient reports sexual dysfunction on antidepressants, determine:

• Specific dysfunction type: Reduced libido, erectile dysfunction, delayed/absent orgasm, or arousal difficulties
• Gender: Management differs significantly between men and women
• Timing: Did symptoms start after antidepressant initiation or dose increase?
• Current antidepressant: SSRIs and SNRIs carry highest risk; bupropion, mirtazapine, and agomelatine have favorable profiles 1, 2, 3
• Depression control: Is the current antidepressant adequately managing depressive symptoms?

Primary Management Strategies

Strategy 1: Switch Antidepressants (Preferred if depression control is suboptimal)

Switch to bupropion, mirtazapine, or nefazodone - these have the lowest rates of sexual dysfunction 1, 2, 4.

• One trial demonstrated that switching from sertraline to nefazodone significantly reduced sexual dysfunction (RR 0.34,95% CI 0.15-0.6) without worsening depression 4
• Bupropion is associated with lower rates of sexual adverse events than SSRIs 5
• This strategy is most appropriate when the current antidepressant provides inadequate symptom control or when the patient prefers monotherapy 1, 6

Strategy 2: Augmentation (Preferred if depression is well-controlled)

For Men with Erectile Dysfunction:

Add sildenafil 50 mg, taken 1 hour before sexual activity 7, 4

• Meta-analysis of 113 men showed sildenafil significantly improved erectile function (WMD 19.36 on IIEF scale, 95% CI 15.00-23.72) 4
• Start with 50 mg; decrease to 25 mg if side effects occur, or increase to 100 mg if ineffective 8
• Contraindication: Absolutely contraindicated with nitrate use due to severe hypotension risk 7, 9, 10
• Alternative PDE5 inhibitors (tadalafil, vardenafil) also effective; tadalafil showed WMD 8.10 improvement in erectile function (95% CI 4.62-11.68) 4
• Choice between PDE5 inhibitors should be based on patient preference, cost, and ease of use 7

For All Sexual Dysfunction Types (Men and Women):

Add bupropion 150-300 mg daily 1, 2, 4, 6

• One trial showed bupropion improved desire-frequency scores (WMD 0.88,95% CI 0.21-1.55) 4
• Particularly effective for reduced libido and orgasmic dysfunction
• Well-tolerated augmentation strategy supported by expert consensus 6

Alternative Augmentation (Limited Evidence):

Saffron (Crocus sativus) shows promise but requires more robust studies 1

Strategy 3: Dose Reduction or Drug Holiday

Reduce antidepressant dose to the minimum effective level 11, 2

• Consider only if depression remains well-controlled at lower doses
• Monitor closely for re-emergence of depressive symptoms
• Drug holidays (skipping doses before planned sexual activity) have theoretical benefit but limited evidence and risk depression relapse 11

Management Algorithm

1. If depression is inadequately controlled: Switch to bupropion, mirtazapine, or nefazodone
2. If depression is well-controlled:
   • Men with erectile dysfunction: Add sildenafil (or tadalafil/vardenafil)
   • Reduced libido or orgasmic dysfunction: Add bupropion
   • Multiple domains affected: Consider switching to bupropion or adding bupropion
3. If switching/augmentation fails: Consider dose reduction if clinically appropriate
4. Monitor: Reassess sexual function and depression control at 4-6 weeks

Critical Pitfalls to Avoid

• Never assume sexual dysfunction is solely from depression itself - antidepressants are a common iatrogenic cause that requires direct intervention 8
• Do not prescribe PDE5 inhibitors without screening for nitrate use - this combination can be fatal 7, 9, 10
• Avoid waiting indefinitely for spontaneous resolution - while tolerance may develop, sexual dysfunction often persists and compromises treatment adherence 2, 4
• Do not ignore female sexual dysfunction - while evidence is more limited, bupropion augmentation and switching strategies apply to women as well 1, 3

Special Considerations

For patients on SSRIs/SNRIs with well-controlled depression: The evidence most strongly supports either switching to bupropion or augmenting with bupropion for general sexual dysfunction, or adding a PDE5 inhibitor specifically for erectile dysfunction in men 4, 6. Expert psychiatrists surveyed most frequently use these strategies and rate them as most effective 6.

Testosterone testing: Consider checking morning testosterone levels in men with reduced libido, as hypogonadism may coexist and respond to testosterone replacement 8, 12. However, routine hormonal testing is not recommended for erectile dysfunction alone 7.

Persistent dysfunction after antidepressant discontinuation (PSSD): This emerging entity requires recognition, though optimal management remains undefined 3. These patients may benefit from referral to sexual medicine specialists.